Publications   |   Conferences    |  Join   |  Sitemap  
Facebook    Twitter     Linkedin     RSS    BLOG    You Tube
 

Journal of Genetic Syndromes & Gene Therapy


Double blind review in 2 weeks     Publishing in 72 hours     Open Access     High Impact
 
ISSN: 2157-7412
 
 
 
HOME » GENETIC-SYNDROMES-GENE-THERAPY French Language  |  English
 
 
 
 
 
 
 
 

In Association with

 

Welcome to the Journal

Editors Recommendation for Indexing

Blum Editor-in-Chief
Kenneth Blum, MD, PhD
Professor, Department of Psychiatry
University of Florida, USA
Tel. +619- 890-2167
E-mail: drd2gene@aol.com
   
Marek Editor-in-Chief
Marek Malecki, MD, PhD
President, PBMEF, San Francisco, USA
Tel. 415-713-4370
E-mail: mm@pbmef.org
 

Impact Factor: 5.89*

ICV: 5.29

 
Genes are the basic physical and functional units of hereditary and are the specific sequences of bases that are carried on chromosomes which encode instruction, ensure the formation of proteins. Deficiency or disorders of genes in cells leads to the genetic disorders resolved with the respected treatment of gene therapies. The different types of viruses used as gene therapy vectors are retroviruses, adenoviruses, adeno-associated viruses, herpes simplex viruses.
 
Journal of Genetic Syndromes & Gene Therapy is an international, peer-reviewed scientific journal emphasizes the documentation of phenotype analysis, birth defects; infant abnormalities including the various inheritant disorders caused by single mutant genes and the changes that occur due to therapy are heritable. The Journal of Genetic Syndromes and Gene Therapy under Open Access Category conveys the latest research information on identification and analysis of the defective gene, vector development, gene transfer, and provides the readership with current clinical applications for the treatment of diseases and comprehensive reviews on all aspects of genetic disorders and gene therapy.
 
Journal of Genetic Syndromes & Gene Therapy is using online manuscript submission, review and tracking systems of Editorial Manager for quality and quick review processing. Review processing is performed by the editorial board members of Journal of Genetic Syndromes and Gene Therapy or outside experts; at least two independent reviewer’s approval followed by editor's approval is required for acceptance of any citable manuscript.
 
Journal of Genetic Syndromes & Gene Therapy encompasses the continuous coverage of all biological and medical aspects of potential gene therapies for the birth defects along with genetic disorders which include treatments for cancers, arthritis, infectious diseases, inherited diseases like cystic fibrosis and Huntington’s disease, and also genetic abnormalities or deficiencies are treated by incorporating specific engineered genes into the infected cells of patient’s body. The Journal of Genetic Syndromes & Gene Therapy provides reliable information updating online viewers with the modified methods and latest advancements in the field of gene therapy for diverse genetic disorders.
 
* Unofficial 2012 Impact Factor was established by dividing the number of articles published in 2010 and 2011 were cited in 2012 based on a search of the Google Scholar Citation Index database, by the number of articles published in the previous two years (2010 and 2011).
X = the number of times, articles published in 2010 and 2011, were cited by indexed journals during 2012
Y = the total number of "citable items" published by that journal in 2010 and 2011.
2012 impact factor = X/Y

 

 

Recently published articles

The Recent Advances and Future Perspectives of Personalized Medicine
Youming Zhang and Xiaodan Yao
 
5-Ht5a Receptors during Ontogeny
Berumen LC and García AG
 
Apolipoprotein Gene Polymorphisms (APOB, APOС111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan
Berkinbayev S, Rysuly M, Mussayev A, Blum K, Baitasova N, Mussagaliyeva A, Dzhunusbekova G, Makhatov B, Mussayev AA, Yeshmanova A,Lesbekova R, Marchuk Y, Azhibekova R, Oscar-Berman M and Kulmaganbetov M
 
Eosinophilic Bronchial Disorders Presenting Chronic Cough; Atopic Cough, Cough Variant Asthma and Non-Asthmatic Eosinophilic Bronchitis
Ishiura Y, Fujimura M and Kasahara K
 
Significant Increase of IL-8 Sputum Levels in Treatment Resistant Severe Asthma Compared with Difficult to Treat Severe Asthma Patients
Glenda E, Auteri S, Fabián C, Daniel C, Fernandez M, Guillermo M, Morero JL, Neffen H and Schiavi E
 
 
 
 
* Calculation of Unofficial Impact Factor
 
 
 
© 2008–2014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version